# A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat

> **NCT05154955** · PHASE2 · COMPLETED · sponsor: **10xBio, LLC** · enrollment: 51 (actual)

## Conditions studied

- Submental Fat

## Interventions

- **DRUG:** 10XB-101 Solution for Injection
- **DRUG:** 10XB-101 Vehicle Solution for Injection

## Key facts

- **NCT ID:** NCT05154955
- **Lead sponsor:** 10xBio, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-19
- **Primary completion:** 2024-03-19
- **Final completion:** 2024-03-19
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154955, "A Safety and Tolerability Study of 10XB-101 Injection in Adult Subjects With Submental Fat". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05154955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*